I-Flow Results Improve
IRVINE — I-Flow Corp. said Monday that it expects third-quarter revenue and operating income to be “significantly” improved from results a year ago.
The company, which designs and develops ambulatory infusion systems, said it expects revenue of about $4 million, up from $2.6 million a year ago, while operating income should climb to 6 cents per share from 4 cents per share.
The income for the quarter ended Sept. 30 does not include a charge that the company expects to record from its acquisition of Block Medical Inc. The transaction will almost double sales and significantly improve distribution, I-Flow said.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.